Company Filing History:
Years Active: 2002
Title: James Gordon Douglas, III: Innovator in Androgen Receptor Therapy
Introduction
James Gordon Douglas, III is a notable inventor based in San Diego, CA. He has made significant contributions to the field of medical research, particularly in the area of androgen receptor suppressors. His work focuses on therapies and diagnostics for conditions such as prostate cancer and alopecia.
Latest Patents
Douglas holds a patent for "Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes." This patent includes substituted phenylalanines that comprise an hydantoin, urea, or 2-hydroxyl, 2-methylpropionyl group, along with dimers and various derivatives. The compounds developed bind specifically to the androgen receptor and are useful in treating conditions associated with androgen receptor activity, including cell hyperplasia, hirsutism, acne, and androgenetic alopecia. He has 1 patent to his name.
Career Highlights
Douglas is currently associated with Biophysica, Inc., where he continues to advance his research and innovations. His work has the potential to impact the treatment of several androgen-related conditions significantly.
Collaborations
He has collaborated with notable professionals in the field, including Milos Sovak and Allen L. Seligson, enhancing the scope and impact of his research.
Conclusion
James Gordon Douglas, III is a prominent figure in the development of androgen receptor therapies, with a focus on improving treatment options for prostate cancer and related conditions. His innovative work continues to pave the way for advancements in medical science.